Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH--an in vitro study.

BACKGROUND Main factors for the overall performance of haemofilters (HF) are membrane features and filter durability without clogging/clotting of capillaries. However, the venous line resistance (Pv) is a powerful force for net filtrate flux resulting in haemoconcentration and thus is enhancing the phenomenon of membrane clogging. Therefore, we hypothesized that catheter type, as it is associated with Pv-levels, contributes to the extent in which filter longevity and filtration performance are restricted due to blocked hollow fibres. METHODS Heparinized porcine blood (5 IU/ml) was circulated in an in vitro system for haemofiltration (FH6S-filters were used, Ca. Gambro). Three different sizes of catheters for peripheral vein access (Vygonuele V, Ca. Vygon) were alternately inserted into the circuit for blood return from the filter to the reservoir. To produce Pv-levels lower than commonly induced by Shaldon catheters, a 14G-vygonuele was used. Pv-levels standard for 11-12 French catheters were provided by using a 16G-vygonuele. To produce Pv-levels common for low-French or tri-lumen catheters, a shortened 18G-vygonuele was used. The respective Pv-levels attained were compared with respect to the overall filtration performance (system pressures, haemocompatibility and sieving coefficients). RESULTS Catheters of 14 and 16G enabled transiently maximal blood flow (Qb)/filtration rates (Qf) of 300/60 ml/min and continuous filtration with Qb/Qf of 200/40 ml/min. The shortened 18G catheter reduced maximal flow rates down to Qb/Qf of 200/40 ml/min, and continuous flow rates down to Qb/Qf of 125/25 ml/min. At the end, median values for blocked hollow fibres were, 35% in the 14G-group, 40% in the 18G-group and 70% in the 16G-group. Haemocompatibility appeared to be higher in the 14G-group with respect to various parameters when compared with the other groups. CONCLUSIONS The flow resistance by the catheter chosen for haemofiltration clearly influenced the filtration performance. Thus, investigations focused on compatibility of catheter type as it related to Pv-levels with the particular method of renal replacement therapy that should be performed. This point could be crucial in reducing filter clogging and haemostasis during CVVH.

[1]  R. Rossaint,et al.  HES130kDa/0.4 and albumin improve CVVH-biocompatibility while gelatine and HES200/0.5 lead to adverse side effects of CVVH in anaesthetized pigs: A-803 , 2006 .

[2]  R. Rossaint,et al.  HYDROXYETHYL STARCH 130 KD/0.4 AND ALBUMIN IMPROVE CVVH BIOCOMPATIBILITY WHEREAS GELATIN AND HYDROXYETHYL STARCH 200 KD/0.5 LEAD TO ADVERSE SIDE EFFECTS OF CVVH IN ANESTHETIZED PIGS , 2006, Shock.

[3]  R. Rossaint,et al.  Albumin and hydroxyethyl starch 130 kDa/0.4 improve filter clearance and haemocompatibility in haemo- and plasmafiltration--an in vitro study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  R. Bellomo,et al.  Blood flow reductions during continuous renal replacement therapy and circuit life , 2004, Intensive Care Medicine.

[5]  R. Rossaint,et al.  Influence of different heparin concentrations on the results of in vitro investigations in plasmaseparation technology using capillary membrane filters. , 2003, Artificial organs.

[6]  G. La Manna,et al.  Standard Heparin versus Low-Molecular-Weight Heparin , 2002, Nephron.

[7]  J. Wester,et al.  Catheter replacement in continuous arteriovenous hemodiafiltration: The balance between infectious and mechanical complications* , 2002, Critical care medicine.

[8]  F. Quarello,et al.  Prevention of Hemodialysis Catheter-Related Bloodstream Infection Using an Antimicrobial Lock , 2002, Blood Purification.

[9]  R. Bellomo,et al.  AN EX-VIVO EVALUATION OF VASCULAR CATHETERS FOR CONTINUOUS HEMOFILTRATION , 2002, Renal failure.

[10]  R. Rossaint,et al.  Enhancing Filtration Rates by the use of Blood Flow around the Capillaries of Plasmafilters: An in Vitro Study , 2001, The International journal of artificial organs.

[11]  R. Rossaint,et al.  The Influence of Hypoalbuminemia on Maximal Flow Rates and Transmembrane Pressure during Plasmapheresis – An in vitro Study , 2001, Blood Purification.

[12]  H. O. Oudemans-van Straaten,et al.  Nadroparin versus dalteparin anticoagulation in high‐volume, continuous venovenous hemofiltration: A double‐blind, randomized, crossover study , 2000, Critical care medicine.

[13]  P. Mertens,et al.  Influence of hematocrit on hemostasis in continuous venovenous hemofiltration during acute renal failure. , 1999, Kidney international. Supplement.

[14]  A. Davenport The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  G. Walters,et al.  A Comparison of the Dual Lumen and Coaxial Catheters for Temporary Hemodialysis Access , 1997, International Journal of Artificial Organs.

[16]  N. Maeda,et al.  Opposite effect of albumin on the erythrocyte aggregation induced by immunoglobulin G and fibrinogen. , 1986, Biochimica et biophysica acta.

[17]  J. Turney,et al.  PLATELET PROTECTION AND HEPARIN SPARING WITH PROSTACYCLIN DURING REGULAR DIALYSIS THERAPY , 1980, The Lancet.

[18]  V. Armstrong,et al.  Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patients. , 1990, ASAIO transactions.